Pharmaust Limited (AU:PAA) has released an update.
Pharmaust Limited has reported a notable change in director Dr. Michael Thurn’s holdings, where he acquired 157,895 fully paid ordinary shares at $0.19 each, totaling $30,000. This transaction, part of the company’s Share Purchase Plan, has increased his indirect interest to 2,557,895 ordinary shares, while maintaining his 500,000 Listed Options and 1,000,000 Unlisted Options.
For further insights into AU:PAA stock, check out TipRanks’ Stock Analysis page.
